MeaCor develops novel transcatheter devices for the treatment of heart disease.
MeaCor has raised $15.0M in total funding. The most recent round was Series A. The last funding was announced in May 2024.
MeaCor's investors include MedTech Innovator.
MeaCor is headquartered in Ayer, United States.
MeaCor develops novel transcatheter devices for the treatment of heart disease.
MeaCor is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"MeaCor — Funding & Investors." VCBacked, May 14, 2024, https://www.vcbacked.co/company/meacor. Accessed October 21, 2026.
VCBacked. (2024). MeaCor — Funding & Investors. Retrieved October 21, 2026, from https://www.vcbacked.co/company/meacor
{{cite web |title=MeaCor — Funding & Investors |url=https://www.vcbacked.co/company/meacor |website=VCBacked |access-date=October 21, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated